These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36361549)
1. Development and In Vitro and In Vivo Evaluation of an Antineoplastic Copper(II) Compound (Casiopeina III-ia) Loaded in Nonionic Vesicles Using Quality by Design. Aguilar-Jiménez Z; González-Ballesteros M; Dávila-Manzanilla SG; Espinoza-Guillén A; Ruiz-Azuara L Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361549 [TBL] [Abstract][Full Text] [Related]
2. Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana. Delgado-Domínguez J; Mejía-Camacho L; Torres-Martínez L; Zamora-Chimal J; Cervantes-Sarabia R; Espinoza-Guillen A; Ruiz-Azuara L; Becker I Chemotherapy; 2024; 69(3):168-176. PubMed ID: 38498996 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effects between a copper-based metal Casiopeína III-ia and cisplatin. Davila-Manzanilla SG; Figueroa-de-Paz Y; Mejia C; Ruiz-Azuara L Eur J Med Chem; 2017 Mar; 129():266-274. PubMed ID: 28231523 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: casiopeina III-Ea, after a single intravenous dose in rats. Vértiz G; García-Ortuño LE; Bernal JP; Bravo-Gómez ME; Lounejeva E; Huerta A; Ruiz-Azuara L Fundam Clin Pharmacol; 2014 Feb; 28(1):78-87. PubMed ID: 22958076 [TBL] [Abstract][Full Text] [Related]
5. Characterization of physical interaction between Casiopeina III-ia and chitosan. Toward a Cas III-ia drug delivery system. Miranda-Calderón JE; Medina-Torres L; Tinoco-Mendez M; Moreno-Esparza R; Ruiz-Ramirez L; Gracia-Mora J; Gracia-Mora I; Bernad-Bernad MJ Carbohydr Res; 2011 Jan; 346(1):121-6. PubMed ID: 21092941 [TBL] [Abstract][Full Text] [Related]
6. Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action. Serment-Guerrero J; Bravo-Gomez ME; Lara-Rivera E; Ruiz-Azuara L J Inorg Biochem; 2017 Jan; 166():68-75. PubMed ID: 27838580 [TBL] [Abstract][Full Text] [Related]
7. Assessment of acute respiratory and cardiovascular toxicity of casiopeinas in anaesthetized dogs. Leal-García M; García-Ortuño L; Ruiz-Azuara L; Gracia-Mora I; Luna-Delvillar J; Sumano H Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):151-8. PubMed ID: 17697033 [TBL] [Abstract][Full Text] [Related]
8. Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and JNK activation. Trejo-Solís C; Jimenez-Farfan D; Rodriguez-Enriquez S; Fernandez-Valverde F; Cruz-Salgado A; Ruiz-Azuara L; Sotelo J BMC Cancer; 2012 Apr; 12():156. PubMed ID: 22540380 [TBL] [Abstract][Full Text] [Related]
9. Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo. Carvallo-Chaigneau F; Trejo-Solís C; Gómez-Ruiz C; Rodríguez-Aguilera E; Macías-Rosales L; Cortés-Barberena E; Cedillo-Peláez C; Gracia-Mora I; Ruiz-Azuara L; Madrid-Marina V; Constantino-Casas F Biometals; 2008 Feb; 21(1):17-28. PubMed ID: 17390215 [TBL] [Abstract][Full Text] [Related]
10. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release. Li C; Cui J; Li Y; Wang C; Li Y; Zhang L; Zhang L; Guo W; Wang J; Zhang H; Hao Y; Wang Y Eur J Pharm Sci; 2008 Aug; 34(4-5):333-44. PubMed ID: 18573336 [TBL] [Abstract][Full Text] [Related]
11. Identification of Casiopeina II-gly secondary targets through a systems pharmacology approach. de Anda-Jáuregui G; Espinal-Enríquez J; Hur J; Alcalá-Corona SA; Ruiz-Azuara L; Hernández-Lemus E Comput Biol Chem; 2019 Feb; 78():127-132. PubMed ID: 30504090 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial effect of Casiopeinas® copper- and ruthenium-based compounds on Aggregatibacter actinomycetemcomitans and in vitro cell viability onto osteoblasts cells. Alberto LA; Georgina CE; Miryam MH; Gabriel TL; Adrian EG; Arelly CB; Lena RA; Antonio ÁM; Manuel MV Braz J Microbiol; 2022 Mar; 53(1):179-184. PubMed ID: 34741282 [TBL] [Abstract][Full Text] [Related]
13. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation. Shaji J; Menon I Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the DNA interaction of copper compounds belonging to the Casiopeínas® antitumoral series. Becco L; García-Ramos JC; Azuara LR; Gambino D; Garat B Biol Trace Elem Res; 2014 Nov; 161(2):210-5. PubMed ID: 25119709 [TBL] [Abstract][Full Text] [Related]
15. Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II. De Vizcaya-Ruiz A; Rivero-Müller A; Ruiz-Ramirez L; Howarth JA; Dobrota M Toxicology; 2003 Dec; 194(1-2):103-13. PubMed ID: 14636700 [TBL] [Abstract][Full Text] [Related]
16. Antigiardiasic activity of Cu(II) coordination compounds: Redox imbalance and membrane damage after a short exposure time. Rufino-González Y; Ponce-Macotela M; García-Ramos JC; Martínez-Gordillo MN; Galindo-Murillo R; González-Maciel A; Reynoso-Robles R; Tovar-Tovar A; Flores-Alamo M; Toledano-Magaña Y; Ruiz-Azuara L J Inorg Biochem; 2019 Jun; 195():83-90. PubMed ID: 30928656 [TBL] [Abstract][Full Text] [Related]
17. Mixed chelate copper complex, Casiopeina IIgly, binds and degrades nucleic acids: a mechanism of cytotoxicity. Rivero-Müller A; De Vizcaya-Ruiz A; Plant N; Ruiz L; Dobrota M Chem Biol Interact; 2007 Feb; 165(3):189-99. PubMed ID: 17217939 [TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of copper-based antineoplastic drugs casiopeinas is related to inhibition of energy metabolism. Hernández-Esquivel L; Marín-Hernández A; Pavón N; Carvajal K; Moreno-Sánchez R Toxicol Appl Pharmacol; 2006 Apr; 212(1):79-88. PubMed ID: 16051288 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. De Vizcaya-Ruiz A; Rivero-Muller A; Ruiz-Ramirez L; Kass GE; Kelland LR; Orr RM; Dobrota M Toxicol In Vitro; 2000 Feb; 14(1):1-5. PubMed ID: 10699355 [TBL] [Abstract][Full Text] [Related]